| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.
Over the last 12 months, insiders at ImmunityBio, Inc. have bought $0 and sold $0 worth of ImmunityBio, Inc. stock.
On average, over the past 5 years, insiders at ImmunityBio, Inc. have bought $15.1M and sold $7.95M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 71,915 shares for transaction amount of $198,023 was made by BLASZYK MICHAEL D (director) on 2023‑06‑05.
| 2023-06-05 | BLASZYK MICHAEL D | director | 71,915 0.0166% | $2.75 | $198,023 | +30.82% | ||
| 2023-06-02 | Brennan John Owen | director | 25,000 0.006% | $2.83 | $70,700 | +31.77% | ||
| 2023-06-02 | Brennan John Owen | director | 15,000 0.0035% | $2.78 | $41,700 | +31.77% | ||
| 2023-06-01 | Clark Wesley | director | 7,000 0.0016% | $2.91 | $20,370 | +24.15% | ||
| 2021-10-08 | Adcock Richard | CEO & President | 1,930 0.0005% | $8.81 | $16,995 | -38.25% | ||
| 2021-08-23 | Sale | Cohen Cheryl | director | 14,801 0.0035% | $10.12 | $149,795 | -45.86% | |
| 2021-08-20 | Sale | Cohen Cheryl | director | 9,976 0.0025% | $10.00 | $99,808 | -41.00% | |
| 2021-08-18 | Sale | Cohen Cheryl | director | 2,133 0.0006% | $10.03 | $21,389 | -36.74% | |
| 2021-08-17 | Sale | Cohen Cheryl | director | 43,398 0.0112% | $10.12 | $439,361 | -41.04% | |
| 2021-05-25 | Sale | Simon Barry J. | director | 88,787 0.0237% | $16.18 | $1.44M | -54.64% | |
| 2021-05-24 | Sale | Simon Barry J. | director | 21,223 0.0056% | $16.02 | $340,071 | -54.46% | |
| 2021-05-21 | Sale | Simon Barry J. | director | 14,990 0.0039% | $16.09 | $241,164 | -53.43% | |
| 2021-02-05 | Sale | Simon Barry J. | See remarks | 22,100 0.0056% | $23.09 | $510,267 | -52.76% | |
| 2021-02-02 | Sale | Simon Barry J. | See remarks | 82,070 0.0212% | $20.65 | $1.69M | -46.10% | |
| 2021-01-28 | Sale | Simon Barry J. | See remarks | 11,304 0.0033% | $20.53 | $232,121 | -39.34% | |
| 2021-01-27 | Sale | Simon Barry J. | See remarks | 36,626 0.01% | $20.61 | $754,946 | -42.76% | |
| 2021-01-12 | Sale | Nelson Sonja | Chief Financial Officer | 16,364 0.004% | $15.00 | $245,460 | -26.52% | |
| 2021-01-04 | Sale | Nelson Sonja | Chief Financial Officer | 39,271 0.0102% | $13.62 | $534,938 | -6.48% | |
| 2020-12-22 | Sale | Simon Barry J. | See remarks | 130,000 0.1231% | $18.05 | $2.35M | -22.23% | |
| 2020-12-10 | Sale | Thomas John C | director | 42,592 0.0385% | $10.83 | $461,122 | +25.09% |
| SOON-SHIONG PATRICK | Chairman and CEO | 23750750 2.6909% | $72.91M | 2 | 0 | <0.0001% |
| Simon Barry J. | director | 3102507 0.3515% | $9.52M | 0 | 20 | |
| Thomas John C | director | 207477 0.0235% | $636,954.39 | 0 | 14 | |
| Cohen Cheryl | director | 200617 0.0227% | $615,894.19 | 0 | 5 | |
| DRISCOLL FREDERICK W | director | 109235 0.0124% | $335,351.45 | 0 | 1 | |
| BLASZYK MICHAEL D | director | 71915 0.0081% | $220,779.05 | 1 | 0 | +30.82% |
| Nelson Sonja | Chief Financial Officer | 15410 0.0017% | $47,308.70 | 0 | 2 | |
| Brennan John Owen | director | 15000 0.0017% | $46,050.00 | 2 | 0 | +31.77% |
| Clark Wesley | director | 8000 0.0009% | $24,560.00 | 1 | 0 | +24.15% |
| Wilson Angela | Chief Financial Officer | 3265 0.0004% | $10,023.55 | 1 | 0 | <0.0001% |
| Adcock Richard | CEO & President | 1930 0.0002% | $5,925.10 | 1 | 0 | <0.0001% |
| GORLIN STEVE | director | 0 0% | $0 | 0 | 30 |
$66,492,695 | 135 | 27.65% | $2.17B | |
$20,363,540 | 75 | 100.86% | $2.17B | |
$11,588,217 | 69 | 42.07% | $2.87B | |
$224,368,761 | 42 | 28.26% | $2.46B | |
$140,165,669 | 33 | 85.24% | $2.68B | |
$5,066,938 | 27 | 26.38% | $2.51B | |
$1,801,511 | 23 | 18.58% | $2.17B | |
$174,105,409 | 15 | 10.88% | $2.37B | |
$70,151,579 | 12 | 22.57% | $3.08B | |
$91,269,919 | 12 | 12.86% | $2.98B | |
$75,296,816 | 12 | 37.23% | $3.06B | |
$35,908,794 | 10 | 126.31% | $3.49B | |
$1,711,150 | 9 | 31.59% | $2.93B | |
$117,959,652 | 9 | -12.47% | $2.81B | |
ImmunityBio, Inc. (IBRX) | $55,713,031 | 8 | -0.36% | $2.71B |
$4,623,072 | 7 | 11.07% | $3.54B | |
$14,400,000 | 5 | 41.34% | $3.52B | |
$276,224 | 2 | -7.04% | $2.27B | |
$49,999,992 | 1 | 50.02% | $2.65B |
| Increased Positions | 123 | +60% | 11M | +13.57% |
| Decreased Positions | 77 | -37.56% | 14M | -17.1% |
| New Positions | 45 | New | 1M | New |
| Sold Out Positions | 34 | Sold Out | 8M | Sold Out |
| Total Postitions | 251 | +22.44% | 80M | -3.52% |
| Vanguard Group Inc | $44,014.00 | 1.97% | 17.33M | +425,713 | +2.52% | 2024-12-31 |
| Blackrock, Inc. | $33,757.00 | 1.51% | 13.29M | -294,686 | -2.17% | 2025-03-31 |
| State Street Corp | $24,854.00 | 1.11% | 9.79M | +1M | +13.06% | 2024-12-31 |
| Morgan Stanley | $10,175.00 | 0.45% | 4.01M | +2M | +78.28% | 2024-12-31 |
| Geode Capital Management, Llc | $9,756.00 | 0.44% | 3.84M | -5,757 | -0.15% | 2024-12-31 |
| Woodline Partners Lp | $8,744.00 | 0.39% | 3.44M | +3M | +682.7% | 2024-12-31 |
| Cormorant Asset Management, Lp | $7,620.00 | 0.34% | 3M | +3M | New | 2024-12-31 |
| Tang Capital Management Llc | $7,148.00 | 0.32% | 2.81M | +3M | New | 2024-12-31 |
| Ubs Group Ag | $4,033.00 | 0.18% | 1.59M | +1M | +290.64% | 2024-12-31 |
| Northern Trust Corp | $3,361.00 | 0.15% | 1.32M | +97,348 | +7.94% | 2024-12-31 |